» Articles » PMID: 33537237

Advances in Lung Cancer Driver Genes Associated With Brain Metastasis

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Feb 4
PMID 33537237
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metastasis, one of the common complications of lung cancer, is an important cause of death in patients with advanced cancer, despite progress in treatment strategies. Lung cancers with positive driver genes have higher incidence and risk of brain metastases, suggesting that driver events associated with these genes might be biomarkers to detect and prevent disease progression. Common lung cancer driver genes mainly encode receptor tyrosine kinases (RTKs), which are important internal signal molecules that interact with external signals. RTKs and their downstream signal pathways are crucial for tumor cell survival, invasion, and colonization in the brain. In addition, new tumor driver genes, which also encode important molecules closely related to the RTK signaling pathway, have been found to be closely related to the brain metastases of lung cancer. In this article, we reviewed the relationship between lung cancer driver genes and brain metastasis, and summarized the mechanism of driver gene-associated pathways in brain metastasis. By understanding the molecular characteristics during brain metastasis, we can better stratify lung cancer patients and alert those at high risk of brain metastasis, which helps to promote individual therapy for lung cancer.

Citing Articles

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.


Regulation of metastatic organotropism.

Dunbar K, Efe G, Cunningham K, Esquea E, Navaridas R, Rustgi A Trends Cancer. 2024; 11(3):216-231.

PMID: 39732596 PMC: 11903188. DOI: 10.1016/j.trecan.2024.11.012.


Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research.

Sampat P, Cortese A, Goodman A, Ghelani G, Mix M, Graziano S Front Oncol. 2024; 14:1411432.

PMID: 39534096 PMC: 11554526. DOI: 10.3389/fonc.2024.1411432.


The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases.

Wang T, Li R, Liu S, Wu Q, Ouyang W, Xie C BMC Cancer. 2024; 24(1):1343.

PMID: 39482635 PMC: 11529596. DOI: 10.1186/s12885-024-13110-y.


Multicenter cohort analysis of anoikis and EMT: implications for prognosis and therapy in lung adenocarcinoma.

Yin L, Zhang Z, Yan Z, Yan Q Discov Oncol. 2024; 15(1):462.

PMID: 39298078 PMC: 11413261. DOI: 10.1007/s12672-024-01293-6.


References
1.
Caetano M, Hassane M, Van H, Bugarin E, Cumpian A, McDowell C . Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer. Nat Commun. 2018; 9(1):4589. PMC: 6214980. DOI: 10.1038/s41467-018-07042-y. View

2.
Li R, Hebert J, Lee T, Xing H, Boussommier-Calleja A, Hynes R . Macrophage-Secreted TNFα and TGFβ1 Influence Migration Speed and Persistence of Cancer Cells in 3D Tissue Culture via Independent Pathways. Cancer Res. 2016; 77(2):279-290. PMC: 5243269. DOI: 10.1158/0008-5472.CAN-16-0442. View

3.
Kim E . Olmutinib: First Global Approval. Drugs. 2016; 76(11):1153-7. DOI: 10.1007/s40265-016-0606-z. View

4.
Kan C, Vargas G, Pape F, Clezardin P . Cancer Cell Colonisation in the Bone Microenvironment. Int J Mol Sci. 2016; 17(10). PMC: 5085707. DOI: 10.3390/ijms17101674. View

5.
Yilmaz M, Christofori G . EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009; 28(1-2):15-33. DOI: 10.1007/s10555-008-9169-0. View